Valuation: Teva Pharmaceutical Industries Limited

Market Cap 39.85B 35B 32.25B 30.15B 56.55B 3,760B 57.59B 387B 150B 1,853B 150B 146B 6,441B P/E 2026 *
34.4x
P/E 2027 * 18.5x
Enterprise Value 50.88B 44.69B 41.18B 38.5B 72.21B 4,801B 73.53B 494B 191B 2,367B 191B 187B 8,224B EV / Sales 2026 *
3.06x
EV / Sales 2027 * 2.78x
Free-Float
88.61%
Yield 2026 *
-
Yield 2027 * -
1 day-0.53%
1 week+8.61%
Current month-3.20%
1 month-1.21%
3 months+16.06%
6 months+7.21%
Current year+9.55%
1 week 31.28
Extreme 31.28
34.69
1 month 30.8
Extreme 30.8
35.47
Current year 27.93
Extreme 27.93
37.34
1 year 14.99
Extreme 14.99
37.34
3 years 7.42
Extreme 7.42
37.34
5 years 6.78
Extreme 6.7791
37.34
10 years 6.07
Extreme 6.07
56.44
Manager TitleAgeSince
Chief Executive Officer 57 2022-12-31
Director of Finance/CFO 53 2019-12-21
Chief Operating Officer 52 2024-06-02
Director TitleAgeSince
Director/Board Member 78 2015-08-31
Chairman 78 2017-02-05
Director/Board Member 54 2017-07-13
Date Insider Type Main position Quantity % Market Cap.
06-17Sell

Chief Operating Officer

-9,989 0.0009%
06-10Sell

Chief Financial Officer

-106,563 0.0091%
06-04Fiscal year

Director

28,984 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%+8.61%+101.12%+347.51% 39.85B
+1.11%+3.15%+43.03%+150.29% 996B
+1.27%+7.22%+60.82%+49.66% 580B
+3.03%+11.87%+30.64%+79.47% 415B
+5.66%-2.44%+22.01%+15.66% 326B
+1.34%+6.74%+32.63%+41.70% 280B
+1.09%+6.90%+37.22%+24.53% 284B
+1.32%+12.69%-27.48%-41.27% 210B
+1.01%+5.31%+26.81%+58.20% 190B
-0.63%+0.69%+17.64%+62.77% 155B
Average +1.42%+2.92%+34.44%+78.85% 347.66B
Weighted average by Cap. +1.68%+2.21%+35.63%+75.15%

Financials

2026 *2027 *
Net sales 16.64B 14.62B 13.47B 12.59B 23.62B 1,570B 24.05B 162B 62.59B 774B 62.49B 61.12B 2,690B 17.24B 15.14B 13.95B 13.04B 24.47B 1,627B 24.91B 167B 64.83B 802B 64.73B 63.32B 2,787B
Net income 1.74B 1.53B 1.41B 1.31B 2.46B 164B 2.51B 16.86B 6.53B 80.78B 6.52B 6.38B 281B 2.72B 2.39B 2.2B 2.06B 3.86B 257B 3.93B 26.41B 10.23B 126B 10.21B 9.99B 440B
Net Debt 11.03B 9.69B 8.93B 8.35B 15.66B 1,041B 15.94B 107B 41.49B 513B 41.43B 40.52B 1,783B 8.01B 7.04B 6.48B 6.06B 11.37B 756B 11.58B 77.8B 30.14B 373B 30.09B 29.43B 1,295B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
26-06-25 US$34.16 -0.19% 2,285,559
26-06-24 US$34.22 +3.04% 7,249,291
26-06-23 US$33.21 +3.14% 5,567,372
26-06-22 US$32.20 +2.29% 6,111,093
26-06-18 US$31.48 -3.32% 12,241,543
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
34.22USD
Average target price
40.90USD
Spread / Average Target
+19.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TEVA Stock